IFIH1 and Aicardi-Goutieres syndrome: Therefore, in this study, we sought to model AGS using iPSCs carrying the IFIH1 R779H mutation to investigate the pathophysiology of the disease and identify potential therapeutic agents that could modulate excessive IFN signaling before irreversible damage occurs.